U.S. Infectious Respiratory Disease Diagnostics Market (2023 - 2030) Size, Share & Trends Analysis Report By Product Type (Instruments, Consumables, Services), By Sample Type, By Technology, By Application By End-use, And Segment Forecasts

Market Segmentation

U.S. Infectious Respiratory Disease Diagnostics Product Type Outlook (Revenue, USD Million, 2018 - 2030)
- Instruments
  - Respiratory Measurement Devices
  - Imaging Tests
  - Other Instruments
- Consumables
- Services
U.S. Infectious Respiratory Disease Diagnostics Sample Type Outlook (Revenue, USD Million, 2018 - 2030)
- Saliva
- Nasopharyngeal Swabs (NPS)
- Anterior Nasal Region
- Blood
- Others
U.S. Infectious Respiratory Disease Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Immunoassay
- Molecular Diagnostics
- Microbiology
- Other technologies
U.S. Infectious Respiratory Disease Diagnostics Application Outlook (Revenue, USD Million, 2018 - 2030)
- COVID-19
- Influenza
- RSV (Respiratory Syncytial Virus)
- Tuberculosis
- Streptococcus Testing
- Other Respiratory Disease Testing
U.S. Infectious Respiratory Disease Diagnostics End-Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Diagnostic Laboratories
- Physician Offices
- Other end-users

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments